J Korean Breast Cancer Soc.  2004 Sep;7(3):185-192. 10.4048/jkbcs.2004.7.3.185.

Clinical, Pathologic and Immunohistochemical Features of Phyllodes Tumor of the Breast

• Ku KB
• Bang MJ
• Choi JW
• Lee YS
• Park JH
• Kim HO
• Jeong MH
• Oh HG
• Bong JG

• KMID: 2006654
• DOI: http://doi.org/10.4048/jkbcs.2004.7.3.185

Abstract

The histological distinction between benign and malignant phyllodes tumors (PT) is often difficult and arbitrary. We analyzed clinical, histological features and expressions of Ki-67 and p53 using immunohistochemistry and estimate its significance in assessing the grade of malignancy and in predicting the clinical behavior of these tumors on 20 cases of PT of the breast (11 benign, 3 low-grade malignancy and 6 high-grade malignancy). Statistically significant differences between benign, low-grade malignant, and high-grade malignant PT by size of tumor, cellular atypism, stromal cellularity, margin of tumor, and number of mitotic figures. The mean labeling index (LI) of Ki-67 in high-grade malignant PT (9.6+/-9.6) was three-fold higher than that in benign PT (2.7+/-2.2), but this difference was not statistically significant (P=0.074). None of the benign PT were positive for p53, whereas 2 of 3 low-grade malignant and 3 of 6 high-grade malignant PT were positive for p53. Statistically significant differences in the pattern of p53 expression existed among the benign, low-grade malignant, and high-grade malignant lesions (P=0.018). Ki-67 LI and p53 expression were associated with numbers of mitotic figure, but were not associated with metastasis (P=0.546 and 0.216). Increased p53 immunoreactivity is present in high-grade and low-grade malignant PTs in contrast to benign PTs, and malignant PT had a higher Ki-67 LI than benign PT. Thus, p53 and Ki-67 expression may assist in distinguishing benign from malignant PT in diagnostically difficult cases.

Keyword

Phyllodes tumor; Ki-67; p53; Prognosis

MeSH Terms

Breast*
Immunohistochemistry
Neoplasm Metastasis
Phyllodes Tumor*
Prognosis